SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-019760
Filing Date
2022-07-19
Accepted
2022-07-19 08:45:34
Documents
15
Period of Report
2022-07-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48051
2 ex10-1.htm EX-10.1 75949
3 ex99-1.htm EX-99.1 21932
4 ex99-1_logo.jpg GRAPHIC 3977
  Complete submission text file 0001493152-22-019760.txt   352221

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnxt-20220713.xsd EX-101.SCH 2959
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnxt-20220713_lab.xml EX-101.LAB 34916
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnxt-20220713_pre.xml EX-101.PRE 22789
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3876
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

IRS No.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 221090460
SIC: 2834 Pharmaceutical Preparations